Lixian Jin

Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results

Adam Brufsky, Linda D. Bosserman, R. Caradonna et al. · Clinical Breast Cancer · 2009 · 214 citations

Medicine, Oncology, Pharmacology +14

Final 5‐year results of Z‐FAST trial

Adam Brufsky, W G Harker, J. Thaddeus Beck et al. · Cancer · 2011 · 190 citations

Medicine, Oncology, Pharmacotherapy +17

Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial

Thierry André, Elena Élez, Heinz‐Josef Lenz et al. · The Lancet · 2025 · 179 citations

Medicine, Oncology, Immunotherapy +12

Integrated Analysis of Zoledronic Acid for Prevention of Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole

Adam Brufsky, Nigel Bundred, Robert E. Coleman et al. · The Oncologist · 2008 · 175 citations

Medicine, Oncology, Pharmacology +17

Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): First results of the CheckMate 8HW study.

Thierry André, Elena Élez, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2024 · 62 citations

Medicine, Oncology, Pharmacology +15